Physician

James Kendel Schwarz, MD

According to 2025 Medicare claims, James Schwarz, MD (NPI: 1710968847) practices medical oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68114-4108. Schwarz is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Maple ACO LLC (ACO ID: A5401), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Schwarz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 198 traditional Medicare patients, billed 71,708 HCPCS/CPT codes, and received $1,345,917 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 450 prescription claims across 87 beneficiaries totaling $1,373,295 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2019 DME data shows 22 claims. Open Payments data shows 17 records totaling $342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $45,638 to $1,345,917. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,676,503 to $1,373,295. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$673K$1.3M2015 Medicare payment: $45,638 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $34,915 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $37,195 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $40,635 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $41,388 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $60,667 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $535,492 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $864,314 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $998,885 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,345,917 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015282938$45,638
2016214722$34,915
2017221705$37,195
2018203654$40,635
2019223699$41,388
20201607,882$60,667
202111834,910$535,492
202211354,360$864,314
202320774,294$998,885
202419871,708$1,345,917

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.1M2015 Drug cost: $1,676,503 (USD; Tot_Drug_Cst)2016 Drug cost: $2,106,924 (USD; Tot_Drug_Cst)2017 Drug cost: $2,896,769 (USD; Tot_Drug_Cst)2018 Drug cost: $3,115,398 (USD; Tot_Drug_Cst)2019 Drug cost: $2,934,374 (USD; Tot_Drug_Cst)2020 Drug cost: $1,836,129 (USD; Tot_Drug_Cst)2021 Drug cost: $1,006,190 (USD; Tot_Drug_Cst)2022 Drug cost: $1,483,262 (USD; Tot_Drug_Cst)2023 Drug cost: $824,122 (USD; Tot_Drug_Cst)2024 Drug cost: $1,373,295 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201591741$1,676,503
201688819$2,106,924
2017106829$2,896,769
201891817$3,115,398
201993780$2,934,374
202075492$1,836,129
202162257$1,006,190
202262321$1,483,262
202378360$824,122
202487450$1,373,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$30K2015 Medicare payment: $29,625 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $7,388 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $945 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201522232$29,625
2016N/R178$7,388
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R22$945
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2963$129
96413Administration of chemotherapy into vein, 1 hour or less44169$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more102235$88
96372Injection of drug or substance under skin or into muscle35131$10
J7050Infusion, normal saline solution, 250 cc44307$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CabometyxCabozantinib S-Malate14366$309,732
LenalidomideLenalidomide16448$236,777
EliquisApixaban161,035$19,321
Tramadol HclTramadol Hcl18374$620
AnastrozoleAnastrozole16958$564

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$342Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Kendel Schwarz, MD?

Tedicare shows public-source Medicare data for James Kendel Schwarz, MD (NPI 1710968847), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Kendel Schwarz, MD have ACO affiliation data?

James Kendel Schwarz, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James Kendel Schwarz, MD?

James Kendel Schwarz, MD is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does James Kendel Schwarz, MD have Open Payments data?

James Kendel Schwarz, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.